Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 13 entries
Sorted by: Best Match Show Resources per page
An updated h-index measures both the primary and total scientific output of a researcher.

Discoveries (Craiova, Romania)

Bucur O, Almasan A, Zubarev R, Friedman M, Nicolson GL, Sumazin P, Leabu M, Nikolajczyk BS, Avram D, Kunej T, Calin GA, Godwin AK, Adami HO, Zaphiropoulos PG, Richardson DR, Schmitt-Ulms G, Westerblad H, Keniry M, Grau GE, Carbonetto S, Stan RV, Popa-Wagner A, Takhar K, Baron BW, Galardy PJ, Yang F, Data D, Fadare O, Yeo KJ, Gabreanu GR, Andrei S, Soare GR, Nelson MA, Liehn EA.
PMID: 26504901
Discoveries (Craiova). 2015 Jul-Sep;3(3). doi: 10.15190/d.2015.42. Epub 2015 Sep 30.

The growing interest in scientometry stems from ethical concerns related to the proper evaluation of scientific contributions of an author working in a hard science. In the absence of a consensus, institutions may use arbitrary methods for evaluating scientists...

Cite
Bucur O, Almasan A, Zubarev R, et al. An updated h-index measures both the primary and total scientific output of a researcher. Discoveries (Craiova). 2015;3(3)doi: 10.15190/d.2015.42.
Bucur, O., Almasan, A., Zubarev, R., Friedman, M., Nicolson, G. L., Sumazin, P., Leabu, M., Nikolajczyk, B. S., Avram, D., Kunej, T., Calin, G. A., Godwin, A. K., Adami, H. O., Zaphiropoulos, P. G., Richardson, D. R., Schmitt-Ulms, G., Westerblad, H., Keniry, M., Grau, G. E., Carbonetto, S., Stan, R. V., Popa-Wagner, A., Takhar, K., Baron, B. W., Galardy, P. J., Yang, F., Data, D., Fadare, O., Yeo, K. J., Gabreanu, G. R., Andrei, S., Soare, G. R., Nelson, M. A., & Liehn, E. A. (2015). An updated h-index measures both the primary and total scientific output of a researcher. Discoveries (Craiova, Romania), 3(3), . https://doi.org/10.15190/d.2015.42
Bucur, Octavian, et al. "An updated h-index measures both the primary and total scientific output of a researcher." Discoveries (Craiova, Romania) vol. 3,3 (2015). doi: https://doi.org/10.15190/d.2015.42
Bucur O, Almasan A, Zubarev R, Friedman M, Nicolson GL, Sumazin P, Leabu M, Nikolajczyk BS, Avram D, Kunej T, Calin GA, Godwin AK, Adami HO, Zaphiropoulos PG, Richardson DR, Schmitt-Ulms G, Westerblad H, Keniry M, Grau GE, Carbonetto S, Stan RV, Popa-Wagner A, Takhar K, Baron BW, Galardy PJ, Yang F, Data D, Fadare O, Yeo KJ, Gabreanu GR, Andrei S, Soare GR, Nelson MA, Liehn EA. An updated h-index measures both the primary and total scientific output of a researcher. Discoveries (Craiova). 2015 Jul-Sep;3(3). doi: 10.15190/d.2015.42. Epub 2015 Sep 30. PMID: 26504901; PMCID: PMC4617786.
Copy Download .nbib Format: NLM
Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,.

Oncoimmunology

Chu Y, Lee S, Shah T, Yin C, Barth M, Miles RR, Ayello J, Morris E, Harrison L, Van de Ven C, Galardy P, Goldman SC, Lim MS, Hermiston M, McAllister-Lucas LM, Giulino-Roth L, Perkins SL, Cairo MS.
PMID: 30546948
Oncoimmunology. 2018 Oct 11;8(1):e1512455. doi: 10.1080/2162402X.2018.1512455. eCollection 2019.

Pediatric and adult patients with recurrent/refractory Burkitt lymphoma (BL) continue to have poor outcomes, emphasizing the need for newer therapeutic agents. Bruton's tyrosine kinase (BTK) is activated following B-cell receptor stimulation and in part regulates normal B-cell development. Ibrutinib,...

Cite
Chu Y, Lee S, Shah T, et al. Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,. Oncoimmunology. 2018;8(1):e1512455doi: 10.1080/2162402X.2018.1512455.
Chu, Y., Lee, S., Shah, T., Yin, C., Barth, M., Miles, R. R., Ayello, J., Morris, E., Harrison, L., Van de Ven, C., Galardy, P., Goldman, S. C., Lim, M. S., Hermiston, M., McAllister-Lucas, L. M., Giulino-Roth, L., Perkins, S. L., & Cairo, M. S. (2019). Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,. Oncoimmunology, 8(1), e1512455. https://doi.org/10.1080/2162402X.2018.1512455
Chu, Yaya, et al. "Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,." Oncoimmunology vol. 8,1 (2019): e1512455. doi: https://doi.org/10.1080/2162402X.2018.1512455
Chu Y, Lee S, Shah T, Yin C, Barth M, Miles RR, Ayello J, Morris E, Harrison L, Van de Ven C, Galardy P, Goldman SC, Lim MS, Hermiston M, McAllister-Lucas LM, Giulino-Roth L, Perkins SL, Cairo MS. Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,. Oncoimmunology. 2018 Oct 11;8(1):e1512455. doi: 10.1080/2162402X.2018.1512455. eCollection 2019. PMID: 30546948; PMCID: PMC6287791.
Copy Download .nbib Format: NLM
Corrigendum: Ubiquitin C-Terminal Hydrolase L1: Biochemical and Cellular Characterization of a Covalent Cyanopyrrolidine-Based Inhibitor.

Chembiochem : a European journal of chemical biology

Krabill AD, Chen H, Hussain S, Feng C, Abdullah A, Hewitt CS, Das C, Aryal UK, Post CB, Wendt MK, Galardy PJ, Flaherty DP.
PMID: 32931129
Chembiochem. 2020 Sep 14;21(18):2701. doi: 10.1002/cbic.202000493. Epub 2020 Aug 25.

No abstract available.

Cite
Krabill AD, Chen H, Hussain S, et al. Corrigendum: Ubiquitin C-Terminal Hydrolase L1: Biochemical and Cellular Characterization of a Covalent Cyanopyrrolidine-Based Inhibitor. Chembiochem. 2020;21(18):2701doi: 10.1002/cbic.202000493.
Krabill, A. D., Chen, H., Hussain, S., Feng, C., Abdullah, A., Hewitt, C. S., Das, C., Aryal, U. K., Post, C. B., Wendt, M. K., Galardy, P. J., & Flaherty, D. P. (2020). Corrigendum: Ubiquitin C-Terminal Hydrolase L1: Biochemical and Cellular Characterization of a Covalent Cyanopyrrolidine-Based Inhibitor. Chembiochem : a European journal of chemical biology, 21(18), 2701. https://doi.org/10.1002/cbic.202000493
Krabill, Aaron D, et al. "Corrigendum: Ubiquitin C-Terminal Hydrolase L1: Biochemical and Cellular Characterization of a Covalent Cyanopyrrolidine-Based Inhibitor." Chembiochem : a European journal of chemical biology vol. 21,18 (2020): 2701. doi: https://doi.org/10.1002/cbic.202000493
Krabill AD, Chen H, Hussain S, Feng C, Abdullah A, Hewitt CS, Das C, Aryal UK, Post CB, Wendt MK, Galardy PJ, Flaherty DP. Corrigendum: Ubiquitin C-Terminal Hydrolase L1: Biochemical and Cellular Characterization of a Covalent Cyanopyrrolidine-Based Inhibitor. Chembiochem. 2020 Sep 14;21(18):2701. doi: 10.1002/cbic.202000493. Epub 2020 Aug 25. PMID: 32931129.
Copy Download .nbib Format: NLM
Keeping an Open Mind: Cognitive Bias in the Evaluation of an Infant with Posterior-Lateral Rib Fractures.

Case reports in pediatrics

Johnson K, Derauf DC, Stetson R, Galardy P, Homme J.
PMID: 29214091
Case Rep Pediatr. 2017;2017:5163094. doi: 10.1155/2017/5163094. Epub 2017 Oct 26.

A four-month-old former premature male is incidentally found to have posterior-lateral rib fractures during evaluation of a febrile illness. This finding led to the initiation of a workup for nonaccidental trauma. A thorough history and physical exam ultimately led...

Cite
Johnson K, Derauf DC, Stetson R, et al. Keeping an Open Mind: Cognitive Bias in the Evaluation of an Infant with Posterior-Lateral Rib Fractures. Case Rep Pediatr. 2017;2017:5163094doi: 10.1155/2017/5163094.
Johnson, K., Derauf, D. C., Stetson, R., Galardy, P., & Homme, J. (2017). Keeping an Open Mind: Cognitive Bias in the Evaluation of an Infant with Posterior-Lateral Rib Fractures. Case reports in pediatrics, 20175163094. https://doi.org/10.1155/2017/5163094
Johnson, Katie, et al. "Keeping an Open Mind: Cognitive Bias in the Evaluation of an Infant with Posterior-Lateral Rib Fractures." Case reports in pediatrics vol. 2017 (2017): 5163094. doi: https://doi.org/10.1155/2017/5163094
Johnson K, Derauf DC, Stetson R, Galardy P, Homme J. Keeping an Open Mind: Cognitive Bias in the Evaluation of an Infant with Posterior-Lateral Rib Fractures. Case Rep Pediatr. 2017;2017:5163094. doi: 10.1155/2017/5163094. Epub 2017 Oct 26. PMID: 29214091; PMCID: PMC5682078.
Copy Download .nbib Format: NLM
Walking the tightrope: UCH-L1 as an mTOR inhibitor and B-cell oncogene.

Oncotarget

Bedekovics T, Hussain S, Galardy PJ.
PMID: 31497243
Oncotarget. 2019 Aug 27;10(50):5124-5125. doi: 10.18632/oncotarget.27154. eCollection 2019 Aug 27.

No abstract available.

Cite
Bedekovics T, Hussain S, Galardy PJ. Walking the tightrope: UCH-L1 as an mTOR inhibitor and B-cell oncogene. Oncotarget. 2019;10(50):5124-5125doi: 10.18632/oncotarget.27154.
Bedekovics, T., Hussain, S., & Galardy, P. J. (2019). Walking the tightrope: UCH-L1 as an mTOR inhibitor and B-cell oncogene. Oncotarget, 10(50), 5124-5125. https://doi.org/10.18632/oncotarget.27154
Bedekovics, Tibor, et al. "Walking the tightrope: UCH-L1 as an mTOR inhibitor and B-cell oncogene." Oncotarget vol. 10,50 (2019): 5124-5125. doi: https://doi.org/10.18632/oncotarget.27154
Bedekovics T, Hussain S, Galardy PJ. Walking the tightrope: UCH-L1 as an mTOR inhibitor and B-cell oncogene. Oncotarget. 2019 Aug 27;10(50):5124-5125. doi: 10.18632/oncotarget.27154. eCollection 2019 Aug 27. PMID: 31497243; PMCID: PMC6718265.
Copy Download .nbib Format: NLM
A cysteine near the C-terminus of UCH-L1 is dispensable for catalytic activity but is required to promote AKT phosphorylation, eIF4F assembly, and malignant B-cell survival.

Cell death discovery

Hussain S, Bedekovics T, Ali A, Zaid O, May DG, Roux KJ, Galardy PJ.
PMID: 31839994
Cell Death Discov. 2019 Dec 10;5:152. doi: 10.1038/s41420-019-0231-1. eCollection 2019.

The enzyme UCH-L1 is a neuro-endocrine and germinal center B-cell marker that contributes to the development and aggressive behavior of mature B-cell malignancies. While mutations in this enzyme have been associated with Parkinson's disease, relatively little is known about...

Cite
Hussain S, Bedekovics T, Ali A, et al. A cysteine near the C-terminus of UCH-L1 is dispensable for catalytic activity but is required to promote AKT phosphorylation, eIF4F assembly, and malignant B-cell survival. Cell Death Discov. 2019;5:152doi: 10.1038/s41420-019-0231-1.
Hussain, S., Bedekovics, T., Ali, A., Zaid, O., May, D. G., Roux, K. J., & Galardy, P. J. (2019). A cysteine near the C-terminus of UCH-L1 is dispensable for catalytic activity but is required to promote AKT phosphorylation, eIF4F assembly, and malignant B-cell survival. Cell death discovery, 5152. https://doi.org/10.1038/s41420-019-0231-1
Hussain, Sajjad, et al. "A cysteine near the C-terminus of UCH-L1 is dispensable for catalytic activity but is required to promote AKT phosphorylation, eIF4F assembly, and malignant B-cell survival." Cell death discovery vol. 5 (2019): 152. doi: https://doi.org/10.1038/s41420-019-0231-1
Hussain S, Bedekovics T, Ali A, Zaid O, May DG, Roux KJ, Galardy PJ. A cysteine near the C-terminus of UCH-L1 is dispensable for catalytic activity but is required to promote AKT phosphorylation, eIF4F assembly, and malignant B-cell survival. Cell Death Discov. 2019 Dec 10;5:152. doi: 10.1038/s41420-019-0231-1. eCollection 2019. PMID: 31839994; PMCID: PMC6904616.
Copy Download .nbib Format: NLM
Rapid Adoption and Implementation of Telehealth Group Psychotherapy During COVID 19: Practical Strategies and Recommendations.

Cognitive and behavioral practice

Puspitasari AJ, Heredia D, Gentry M, Sawchuk C, Theobald B, Moore W, Tiede M, Galardy C, Schak K.
PMID: 34188434
Cogn Behav Pract. 2021 Nov;28(4):492-506. doi: 10.1016/j.cbpra.2021.05.002. Epub 2021 Jun 24.

Behavioral health services have been tasked with rapidly adopting and implementing teletherapy during the SARS-CoV-2/COVID-19 pandemic to assure patient and staff safety. Existing teletherapy guidelines were developed prior to the pandemic and do not capture the nuances of rapidly...

Cite
Puspitasari AJ, Heredia D, Gentry M, et al. Rapid Adoption and Implementation of Telehealth Group Psychotherapy During COVID 19: Practical Strategies and Recommendations. Cogn Behav Pract. 2021;28(4):492-506doi: 10.1016/j.cbpra.2021.05.002.
Puspitasari, A. J., Heredia, D., Gentry, M., Sawchuk, C., Theobald, B., Moore, W., Tiede, M., Galardy, C., & Schak, K. (2021). Rapid Adoption and Implementation of Telehealth Group Psychotherapy During COVID 19: Practical Strategies and Recommendations. Cognitive and behavioral practice, 28(4), 492-506. https://doi.org/10.1016/j.cbpra.2021.05.002
Puspitasari, Ajeng J, et al. "Rapid Adoption and Implementation of Telehealth Group Psychotherapy During COVID 19: Practical Strategies and Recommendations." Cognitive and behavioral practice vol. 28,4 (2021): 492-506. doi: https://doi.org/10.1016/j.cbpra.2021.05.002
Puspitasari AJ, Heredia D, Gentry M, Sawchuk C, Theobald B, Moore W, Tiede M, Galardy C, Schak K. Rapid Adoption and Implementation of Telehealth Group Psychotherapy During COVID 19: Practical Strategies and Recommendations. Cogn Behav Pract. 2021 Nov;28(4):492-506. doi: 10.1016/j.cbpra.2021.05.002. Epub 2021 Jun 24. PMID: 34188434; PMCID: PMC8223010.
Copy Download .nbib Format: NLM
A Bayesian region of measurement equivalence (ROME) approach for establishing measurement invariance.

Psychological methods

Zhang Y, Lai MHC, Palardy GJ.
PMID: 35007105
Psychol Methods. 2022 Jan 10; doi: 10.1037/met0000455. Epub 2022 Jan 10.

Measurement invariance research has focused on identifying biases in test indicators measuring a latent trait across two or more groups. However, relatively little attention has been devoted to the practical implications of noninvariance. An important question is whether noninvariance...

Cite
Zhang Y, Lai MHC, Palardy GJ. A Bayesian region of measurement equivalence (ROME) approach for establishing measurement invariance. Psychol Methods. 2022;doi: 10.1037/met0000455.
Zhang, Y., Lai, M. H. C., & Palardy, G. J. (2022). A Bayesian region of measurement equivalence (ROME) approach for establishing measurement invariance. Psychological methods, . https://doi.org/10.1037/met0000455
Zhang, Yichi, et al. "A Bayesian region of measurement equivalence (ROME) approach for establishing measurement invariance." Psychological methods vol. (2022). doi: https://doi.org/10.1037/met0000455
Zhang Y, Lai MHC, Palardy GJ. A Bayesian region of measurement equivalence (ROME) approach for establishing measurement invariance. Psychol Methods. 2022 Jan 10; doi: 10.1037/met0000455. Epub 2022 Jan 10. PMID: 35007105.
Copy Download .nbib Format: NLM
USP44 Stabilizes DDB2 to Facilitate Nucleotide Excision Repair and Prevent Tumors.

Frontiers in cell and developmental biology

Zhang Y, Mandemaker IK, Matsumoto S, Foreman O, Holland CP, Lloyd WR, Sugasawa K, Vermeulen W, Marteijn JA, Galardy PJ.
PMID: 33937266
Front Cell Dev Biol. 2021 Apr 16;9:663411. doi: 10.3389/fcell.2021.663411. eCollection 2021.

Nucleotide excision repair (NER) is a pathway involved in the repair of a variety of potentially mutagenic lesions that distort the DNA double helix. The ubiquitin E3-ligase complex UV-DDB is required for the recognition and repair of UV-induced cyclobutane...

Cite
Zhang Y, Mandemaker IK, Matsumoto S, et al. USP44 Stabilizes DDB2 to Facilitate Nucleotide Excision Repair and Prevent Tumors. Front Cell Dev Biol. 2021;9:663411doi: 10.3389/fcell.2021.663411.
Zhang, Y., Mandemaker, I. K., Matsumoto, S., Foreman, O., Holland, C. P., Lloyd, W. R., Sugasawa, K., Vermeulen, W., Marteijn, J. A., & Galardy, P. J. (2021). USP44 Stabilizes DDB2 to Facilitate Nucleotide Excision Repair and Prevent Tumors. Frontiers in cell and developmental biology, 9663411. https://doi.org/10.3389/fcell.2021.663411
Zhang, Ying, et al. "USP44 Stabilizes DDB2 to Facilitate Nucleotide Excision Repair and Prevent Tumors." Frontiers in cell and developmental biology vol. 9 (2021): 663411. doi: https://doi.org/10.3389/fcell.2021.663411
Zhang Y, Mandemaker IK, Matsumoto S, Foreman O, Holland CP, Lloyd WR, Sugasawa K, Vermeulen W, Marteijn JA, Galardy PJ. USP44 Stabilizes DDB2 to Facilitate Nucleotide Excision Repair and Prevent Tumors. Front Cell Dev Biol. 2021 Apr 16;9:663411. doi: 10.3389/fcell.2021.663411. eCollection 2021. PMID: 33937266; PMCID: PMC8085418.
Copy Download .nbib Format: NLM
Development of a bipolar disorder biobank: differential phenotyping for subsequent biomarker analyses.

International journal of bipolar disorders

Frye MA, McElroy SL, Fuentes M, Sutor B, Schak KM, Galardy CW, Palmer BA, Prieto ML, Kung S, Sola CL, Ryu E, Veldic M, Geske J, Cuellar-Barboza A, Seymour LR, Mori N, Crowe S, Rummans TA, Biernacka JM.
PMID: 26105627
Int J Bipolar Disord. 2015 Dec;3(1):30. doi: 10.1186/s40345-015-0030-4. Epub 2015 Jun 24.

BACKGROUND: We aimed to establish a bipolar disorder biobank to serve as a resource for clinical and biomarker studies of disease risk and treatment response. Here, we describe the aims, design, infrastructure, and research uses of the biobank, along...

Cite
Frye MA, McElroy SL, Fuentes M, et al. Development of a bipolar disorder biobank: differential phenotyping for subsequent biomarker analyses. Int J Bipolar Disord. 2015;3(1):30doi: 10.1186/s40345-015-0030-4.
Frye, M. A., McElroy, S. L., Fuentes, M., Sutor, B., Schak, K. M., Galardy, C. W., Palmer, B. A., Prieto, M. L., Kung, S., Sola, C. L., Ryu, E., Veldic, M., Geske, J., Cuellar-Barboza, A., Seymour, L. R., Mori, N., Crowe, S., Rummans, T. A., & Biernacka, J. M. (2015). Development of a bipolar disorder biobank: differential phenotyping for subsequent biomarker analyses. International journal of bipolar disorders, 3(1), 30. https://doi.org/10.1186/s40345-015-0030-4
Frye, Mark A, et al. "Development of a bipolar disorder biobank: differential phenotyping for subsequent biomarker analyses." International journal of bipolar disorders vol. 3,1 (2015): 30. doi: https://doi.org/10.1186/s40345-015-0030-4
Frye MA, McElroy SL, Fuentes M, Sutor B, Schak KM, Galardy CW, Palmer BA, Prieto ML, Kung S, Sola CL, Ryu E, Veldic M, Geske J, Cuellar-Barboza A, Seymour LR, Mori N, Crowe S, Rummans TA, Biernacka JM. Development of a bipolar disorder biobank: differential phenotyping for subsequent biomarker analyses. Int J Bipolar Disord. 2015 Dec;3(1):30. doi: 10.1186/s40345-015-0030-4. Epub 2015 Jun 24. PMID: 26105627; PMCID: PMC4478187.
Copy Download .nbib Format: NLM
Discoveries: an innovative platform for publishing cutting-edge research discoveries in medicine, biology and chemistry.

Discoveries (Craiova, Romania)

Bucur O, Almasan A, Nikolajczyk BS, Nicolson GL, Lawler J, Velculescu VE, Draghici S, Leabu M, Avram D, Bucur I, Calautti E, Calin GA, Chauhan SC, Ciubotaru M, Constantinescu SN, Datta D, Duda DG, Friedman MT, Galardy PJ, Harris BT, Huarte M, Khalil AM, Marchetti D, Movileanu L, Nat R, Nucera C, Popa-Wagner A, Stancu AL, Zhu S, Liehn EA.
PMID: 32309535
Discoveries (Craiova). 2013 Dec 31;1(1):e1. doi: 10.15190/d.2013.1.

Discoveries is a new peer-reviewed, open access, online multidisciplinary and integrative journal publishing high impact reviews, experimental articles, perspective articles, and editorials from all areas related to medicine, biology, and chemistry, including but not limited to: Molecular and Cellular...

Cite
Bucur O, Almasan A, Nikolajczyk BS, et al. Discoveries: an innovative platform for publishing cutting-edge research discoveries in medicine, biology and chemistry. Discoveries (Craiova). 2013;1(1):e1doi: 10.15190/d.2013.1.
Bucur, O., Almasan, A., Nikolajczyk, B. S., Nicolson, G. L., Lawler, J., Velculescu, V. E., Draghici, S., Leabu, M., Avram, D., Bucur, I., Calautti, E., Calin, G. A., Chauhan, S. C., Ciubotaru, M., Constantinescu, S. N., Datta, D., Duda, D. G., Friedman, M. T., Galardy, P. J., Harris, B. T., Huarte, M., Khalil, A. M., Marchetti, D., Movileanu, L., Nat, R., Nucera, C., Popa-Wagner, A., Stancu, A. L., Zhu, S., & Liehn, E. A. (2013). Discoveries: an innovative platform for publishing cutting-edge research discoveries in medicine, biology and chemistry. Discoveries (Craiova, Romania), 1(1), e1. https://doi.org/10.15190/d.2013.1
Bucur, Octavian, et al. "Discoveries: an innovative platform for publishing cutting-edge research discoveries in medicine, biology and chemistry." Discoveries (Craiova, Romania) vol. 1,1 (2013): e1. doi: https://doi.org/10.15190/d.2013.1
Bucur O, Almasan A, Nikolajczyk BS, Nicolson GL, Lawler J, Velculescu VE, Draghici S, Leabu M, Avram D, Bucur I, Calautti E, Calin GA, Chauhan SC, Ciubotaru M, Constantinescu SN, Datta D, Duda DG, Friedman MT, Galardy PJ, Harris BT, Huarte M, Khalil AM, Marchetti D, Movileanu L, Nat R, Nucera C, Popa-Wagner A, Stancu AL, Zhu S, Liehn EA. Discoveries: an innovative platform for publishing cutting-edge research discoveries in medicine, biology and chemistry. Discoveries (Craiova). 2013 Dec 31;1(1):e1. doi: 10.15190/d.2013.1. PMID: 32309535; PMCID: PMC6919543.
Copy Download .nbib Format: NLM
Gamow-Teller transition strengths from 56Ni.

Physical review letters

Sasano M, Perdikakis G, Zegers RG, Austin SM, Bazin D, Brown BA, Caesar C, Cole AL, Deaven JM, Ferrante N, Guess CJ, Hitt GW, Meharchand R, Montes F, Palardy J, Prinke A, Riley LA, Sakai H, Scott M, Stolz A, Valdez L, Yako K.
PMID: 22181727
Phys Rev Lett. 2011 Nov 11;107(20):202501. doi: 10.1103/PhysRevLett.107.202501. Epub 2011 Nov 07.

A new technique to measure (p,n) charge-exchange reactions in inverse kinematics at intermediate energies on unstable isotopes was successfully developed and used to study the (56)Ni(p,n) reaction at 110 MeV/u. Gamow-Teller transition strengths from (56)Ni leading to (56)Cu were...

Cite
Sasano M, Perdikakis G, Zegers RG, et al. Gamow-Teller transition strengths from 56Ni. Phys Rev Lett. 2011;107(20):202501doi: 10.1103/PhysRevLett.107.202501.
Sasano, M., Perdikakis, G., Zegers, R. G., Austin, S. M., Bazin, D., Brown, B. A., Caesar, C., Cole, A. L., Deaven, J. M., Ferrante, N., Guess, C. J., Hitt, G. W., Meharchand, R., Montes, F., Palardy, J., Prinke, A., Riley, L. A., Sakai, H., Scott, M., Stolz, A., Valdez, L., & Yako, K. (2011). Gamow-Teller transition strengths from 56Ni. Physical review letters, 107(20), 202501. https://doi.org/10.1103/PhysRevLett.107.202501
Sasano, M, et al. "Gamow-Teller transition strengths from 56Ni." Physical review letters vol. 107,20 (2011): 202501. doi: https://doi.org/10.1103/PhysRevLett.107.202501
Sasano M, Perdikakis G, Zegers RG, Austin SM, Bazin D, Brown BA, Caesar C, Cole AL, Deaven JM, Ferrante N, Guess CJ, Hitt GW, Meharchand R, Montes F, Palardy J, Prinke A, Riley LA, Sakai H, Scott M, Stolz A, Valdez L, Yako K. Gamow-Teller transition strengths from 56Ni. Phys Rev Lett. 2011 Nov 11;107(20):202501. doi: 10.1103/PhysRevLett.107.202501. Epub 2011 Nov 07. PMID: 22181727.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 13 entries